NEWSBRIEF

NEWSBRIEF

While RNA interference is widely considered one of the most important tools available to researchers studying gene function, the technology does have its limitations. Subscribers: click headline for more

NEWSBRIEF

Beckman Coulter said last week that Robert Hurley has been named vice president of human resources and corporate communications effective May 23.

While a number of companies are competing for proteomics researchers favor on big-ticket items like mass spectrometers, other firms are vying for market share for lower-end equipment common to every lab doing protein research. Subscribers: click headline for more

At A Glance Name: Elizabeth Blackburn Position: Professor, biochemistry/biophysics, microbiology/immunology, University of California, San Francisco

OncoGenex Licenses Cancer Target, Which Is Added to Isis Collaboration

Aaron Timperman

NEWSBRIEF

NEWSBRIEF

NEWSBRIEF

Subscribers: click headline for more

Waters Will Add Matrix Search Engine to its Protein-ID Software Matrix Science's Mascot interface will become part of Waters' protein informatics platform, the companies said this week.

Expression Pathology introduced last week its patent-pending Liquid Tissue MS Protein Prep Kit which allows for the extraction of proteins directly from formalin-fixed paraffin-embedded tissue.

During the 30 years that Memorial Sloan-Kettering scientist Phuong-Van Luc investigated transcriptional regulation, no database existed for quickly finding out if a protein was part of a complex. As a result, Luc was left with few clues to help understand the function of a newly identified protein. Subscribers: click headline for more

Title: Nucleic Acid and Corresponding Protein Entitled 98P4B6 Useful in Treatment and Detection of Cancer. Number: 20050086707. Filed: June 4, 2004. Inventor: Aya Jakobovits, Agensys.

NEWSBRIEF

NEWSBRIEF

NEWSBRIEF

Ambion has recently introduced Pre-miR miRNA precursor molecules.

Calando Pharmaceuticals, an RNAi therapeutics firm founded in February, released last week preclinical data demonstrating that siRNAs delivered with the company s proprietary technology were able to inhibit tumor growth in a mouse model of Ewing s sarcoma without stimulating an interferon response. Subscribers: click headline for more

Beckman to Buy Agencourt For Up to $140M; Plans New 'Personal Genomics' Spin-Off Beckman Coulter intends to purchase Agencourt Bioscience for up to $140 million in cash, the companies said this week.

NEWSBRIEF

NEWSBRIEF